Olea europaea leaf extract alters microRNA expression in human glioblastoma cells
- 882 Downloads
Glioblastoma multiforme (GBM) is the most common and the most lethal form of primary malignant tumors in the central nervous system. There is an increasing need for the development of more efficient therapeutic approaches for the treatment of these patients. One of the most attractive cancer therapy methods to date is the induction of tumor cell death by certain phytochemicals. Interestingly, bioactive compounds have been shown to alter micro RNA (miRNA) expression involved in several biological processes at the posttranscriptional level. The present study aimed to evaluate whether Olea europaea leaf extract (OLE) has an anticancer effect and modulates miRNA expression in GBM.
Materials and methods
Firstly, the anti-proliferative activity of OLE and the nature of the interaction with temozolomide (TMZ) of OLE were tested in human glioblastoma cell line T98G cells by trypan blue and WST-1 assays and than realized miRNA PCR array analysis. Potential mRNA targets were analyzed bioinformatically.
OLE exhibited anti-proliferative effects on T98G cell lines. Cells were treated with temozolomide (TMZ) in the presence OLE, and changes to miRNA expression levels were identified by PCR array analysis. miRNA target genes are involved in cell cycle and apoptotic pathways. Specifically, miR-181b, miR-153, miR-145, miR-137, and let-7d were significantly upregulated after treatment with both TMZ and OLE.
Our results suggest that OLE modulates the expression of some miRNAs related to anticancer activity in GBM and the response to TMZ. Further studies and validations are needed, but we suggest that OLE might be used for in vivo studies and future medical drug studies.
KeywordsOlea europaea leaf extract Temozolomide Glioblastoma multiforme MicroRNA
We thank the Kale Naturel for kindly providing OLE and Prof. Turkkan Evrensel, Uludag University of Turkey, for kindly providing TMZ. This study was supported by a grant from the Scientific Research Projects Foundation (BAP) of the Uludag University of Turkey [Project No. UAP (T)-2010/7].
Conflict of interest
- Chistiakov DA, Chekhonin VP (2012) Contribution of microRNAs to radio-and chemoresistance of brain tumors and their therapeutic potential. Eur J Pharmacol. doi: 10.1016/j.ejphar.2012.03.031
- Craig WJ (1999) Health-promoting properties of common herbs. Am J Clin Nutr 70:491–495Google Scholar
- Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafà R, Magri E, Lunardi M, Munerato G, Querzoli G, Maestri I, Ulazzi L, Nenci I, Croce CM, Lanza G, Querzoli P, Negrini M (2011) MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J Pathol 225:43–53PubMedCrossRefGoogle Scholar
- Fu S, Arráez-Roman D, Segura-Carretero A, Menéndez JA, Menéndez-Gutiérrez MP, Micol V, Fernández-Gutiérrez A (2010) Qualitative screening of phenolic compounds in olive leaf extracts by hyphenated liquid chromatography and preliminary evaluation of cytotoxic activity against human breast cancer cells. Anal Bioanal Chem 397:643–654PubMedCrossRefGoogle Scholar
- Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer 67:2456–2468Google Scholar
- miRBase: the microRNA database. release 17; April 2011 [cited 2011 Sept 15]. Available from: http://www.mirbase.org
- Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihuesi P (2005) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892–6899CrossRefGoogle Scholar
- Sharon AR, Cindy DD (2011) MicroRNA, Nutrition, and Cancer Prevention American Society for nutrition. Adv Nutr 2:472–485Google Scholar
- Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA et al (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6:14PubMedCrossRefGoogle Scholar